Title: Fleming Fund inception phase
Date: January - May 2017
Location: Nepal & Myanmar
Client: Fleming Fund through Mott MacDonald
Type of services:
[5 Mar 2017] Linda Oskam is currently in Myanmar and Nepal on a scoping mission for the Fleming Fund to assess the antimicrobial resistance (AMR) situation and the surveillance capacity in these countries.
The Fleming Fund is an initiative of the UK Department of Health and aims to support around 30 countries worldwide to improve their AMR surveillance capacity up to the level that they can report to GLASS (Global Antimicrobial Resistance Surveillance System). One Health, sustainability, country ownership and alignment with policies and other initiatives are crucial to the program.
Mott MacDonald serves as the Fleming Fund Management Agent and Linda was hired to serve as a laboratory expert during the inception phase. Currently, Mott MacDonald teams are carrying out scoping missions to get a better understanding of the AMR surveillance situation in Myanmar, Nepal, Ghana and Uganda, to raise awareness among stakeholders, to test the approaches and tools that were developed so far and (ultimately) to get grant proposals from the countries involved.
In Myanmar we had a meeting with the Minister of Health and Sports, His Excellency Dr. Myint Htwe, who was very supportive. Source: //blog.datos-advice.nl/#post23
Title: Assessment of the Mycobacterial Research Laboratory
Date: December 2016
Client: The Leprosy Mission Nepal
Type of services:
Assessment of the Mycobacterial Research Laboratory with advice for future activities and improvements of current services.
[6 Dec 2016] From 5 to 7 December 2016 Linda Oskam was in Anandaban (Nepal, just south of Kathmandu) for the mid-term review of the research activities of Anandaban Hospital and the Mycobacterial Research Laboratory.
Anandaban Hospital provides specialized leprosy care for leprosy patients from all over Nepal with support from The Leprosy Mission Nepal and The Leprosy Mission International. Apart from diagnosis and treatment, care for complications, surgery and social rehabilitation, Anandaban Hospital also performs research into all aspects of leprosy. As leprosy is a neglected tropical disease that mostly hits the poorest people in developing countries, Anandaban Hospital and its Research Laboratory are one of the few remaining high level leprosy research centers in the world.
In 2007 and 2013, Linda Oskam was involved in the mid-term reviews of the research and laboratory activities. During the current review and assessment a team of 3 experts went over all the research activities and discussed current successes and challenges as well as opportunities for improvement and expansion. This will help Anandaban Hospital to continue its world class research activities that are crucial for our understanding of the biological, epidemiological and social context of leprosy and help to provide state of the art care for all leprosy patients worldwide. Source: //blog.datos-advice.nl/#post18